Probiotics at the service of “fatty liver” syndrome
To lighten the global burden of metabolic diseases, we would need to be able to make a large part of the planet adopt healthier dietary habits. A necessary but difficult task. Simultaneously, interventions at the heart of intestinal bacterial dynamics are under consideration: will probiotics and fecal microbiota transplants be the great new metabolic therapies of tomorrow?

About this article
Created
26 September 2019
Updated
30 December 2021
Old sources